NISHIYAMA Hiroyuki

Researcher's full information

Articles

• The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database
  Koguchi Tomoyuki; Naito Sei; Hatakeyama Shingo; Numaku...
  CANCER MEDICINE/Epub, 2023-10-31
• Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group
  Horie Shigemitsu; Naito Sei; Hatakeyama Shingo; Kandor...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(11:SI)/pp.1538-1544, 2023-11
• Perioperative enfortumab vedotin (EV) plus pembrolizumab (pembro) versus chemotherapy in cisplatin-eligible patients (pts) with muscle-invasive bladder cancer (MIBC): Phase 3 KEYNOTE-B15/EV-304.
  Hoimes Christopher J.; Loriot Yohann; Bedke Jens; Nish...
  JOURNAL OF CLINICAL ONCOLOGY/41(6), 2023-02-20
• Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial
  Kimura Tomokazu; Ishikawa Hitoshi; Nagumo Yoshiyuki; S...
  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS/117(3)/pp.644-651, 2023-11-01
• Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
  Mishima Saori; Naito Yoichi; Akagi Kiwamu; Hayashi Na...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1237-1258, 2023-10
• Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
  Ando Yuichi; Nishiyama Hiroyuki; Shimodaira Hideki; Ta...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1315-1332, 2023-10
• Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study
  Koyama Juntaro; Yamashita Shinichi; Kakimoto Kenichi; ...
  INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2023-07-31
• Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
  Nishiyama Hiroyuki; Inoue Takamitsu; Koizumi Yuichi; K...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1298-1314, 2023-10
• Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study
  Nishiyama Hiroyuki; Tsuzuki Toyonori; Ohyama Chikara; ...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1398-1410, 2023-10
• Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
  Nishiyama Hiroyuki; Tanaka Yu; Hamada Masahiro; Ozaki ...
  BMC CANCER/23(1), 2023-06-20
• Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
  Hamada Kazuki; Nagumo Yoshiyuki; Kandori Shuya; Tanuma...
  ONCOLOGY LETTERS/26(3), 2023-09
• Re: Predictive Biomarkers for Survival Benefit With Ramucirumab in Urothelial Cancer in the RANGE Trial Editorial Comment
  van der Heijden M. S.; Powles T.; Petrylak D.; de Wit ...
  JOURNAL OF UROLOGY/209(1)/pp.291-291, 2023-01
• Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
  Naito Yoichi; Mishima Saori; Akagi Kiwamu; Hayashi Na...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(7:SI)/pp.827-840, 2023-07
• Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
  Mishima Saori; Naito Yoichi; Akagi Kiwamu; Hayashi Na...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(8:SI)/pp.941-955, 2023-08
• Can cystoscopy artificial intelligence overcome differences between cystoscope products?
  Ikeda A.; Nosato H.; Takaoka S.; Negoro H.; Sakanashi...
  EUROPEAN UROLOGY/83(1)/pp.S845-S845, 2023-02
• A need for clear definitions and improved management for BCG-unresponsive tumors in Asia-Pacific
  Lee L. S.; Kanesvaran R.; Kikuchi E.; Kitamura H.; Ku...
  ANNALS OF ONCOLOGY/33(9)/pp.S1491-S1491, 2022-11
• Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052
  Lee J-L.; Keam B.; Kanesvaran R.; Yamamoto Y.; Su W-...
  ANNALS OF ONCOLOGY/33(9)/pp.S1485-S1486, 2022-11
• Use of neoadjuvant chemotherapy for non-metastatic muscle-invasive bladder cancer in Asia-Pacific
  Kanesvaran R.; Kikuchi E.; Kitamura H.; Ku J. H.; Lee...
  ANNALS OF ONCOLOGY/33(9)/pp.S1491-S1492, 2022-11
• Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART): An open-label, single-arm, multicenter, phase II trial
  Nagumo Y.; Kimura T.; Ishikawa H.; Sekino Y.; Maruo ...
  ANNALS OF ONCOLOGY/33(7:7)/pp.S1332-S1333, 2022-09
• [Maturation and Development of the"All Japan E-Learning Cloud of the Training Program for Oncology Professionals]
  Kim Jaejeong; Owada Yohei; Kojo Kosuke; Sanuki Masaru...
  Gan to kagaku ryoho. Cancer & chemotherapy/49(5)/pp.520-524, 2022-05-01
  
  PubMed
• [Management of Chronic Kidney Disease in Cancer Survivors]
  Kondoh Chihiro; Ishikura Kenji; Ichioka Satoko; Omae ...
  Gan to kagaku ryoho. Cancer & chemotherapy/49(11)/pp.1200-1204, 2022-11-01
  
  PubMed
• [Management of Chronic Kidney Disease in Cancer Survivors]
  Kondoh Chihiro; Ishikura Kenji; Ichioka Satoko; Omae ...
  Gan to kagaku ryoho. Cancer & chemotherapy/49(11)/pp.1200-1204, 2022-11-01
  
  PubMed
• [Two Cases of Femoral Nerve Palsy after Pelvic Surgery]
  Kinase Satoka; Hoshi Akio; Iimura Tsubasa; Sakurai Hi...
  Hinyokika kiyo. Acta urologica Japonica/69(1)/pp.25-28, 2023-01-01
  
  PubMed
• Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial
  Tomita Yoshihiko; Kobayashi Ko; Kimura Go; Oya Mototsugu...
  JAPANESE JOURNAL OF CLINICAL ONCOLOGY/53(1)/pp.16-25, 2023-01-06
  
  PubMed
• C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guerin therapy: A Japan Urological Oncology Group study analysis
  Nishikawa Ryoma; Miyake Makito; Morizane Shuichi; Shim...
  INTERNATIONAL JOURNAL OF UROLOGY/30(3)/pp.299-307, 2023-03-01
  
  PubMed
• more...